Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prevail Therapeutics
Biotech
Lilly's Prevail walks away from Precision gene editing collab
Nine months after Lilly’s Prevail Therapeutics reduced the biobucks value of a gene editing deal with Precision, the Big Pharma unit has walked away.
James Waldron
Apr 17, 2024 8:48am
Lilly to build new pearly Gate(way) in sunny San Diego
Nov 28, 2023 10:40am
Lilly's Prevail inks $1B-plus biobucks deal with Sangamo
Jul 17, 2023 10:29am
Lilly's Prevail drops deal value for Precision gene therapy pact
Jul 7, 2023 10:30am
Scribe's CRISPR tech Prevails with new $1.5B Lilly biobucks deal
May 16, 2023 9:00am
Lilly doubles down on Prevail buy with $700M research hub
Feb 22, 2022 9:34am
